Iranian consensus on use of vitamin D in patients with multiple sclerosis
- PMID: 27209163
- PMCID: PMC4875642
- DOI: 10.1186/s12883-016-0586-3
Iranian consensus on use of vitamin D in patients with multiple sclerosis
Abstract
Background: Accumulating evidences from experimental, epidemiologic and clinical studies support the potential linkage between poor vitamin D status and the risk of developing Multiple Sclerosis (MS), as well as, an adverse disease course. However, the results of the trials on the clinical outcomes of vitamin D supplementation in MS patients are less consistent which brought many discrepancies in routine practice. In this article we presented a summary of a symposium on vitamin D and MS. In this symposium we aim to review the current data about the relationship between vitamin D and MS, and suggest management guides for practicing neurologists.
Discussion: Generally, supplementation seems to be reasonable for all MS and clinically isolated syndrome (Rinaldi et al., Toxins 7:129-37, 2015) patients with serum 25(OH)D level below 40 ng/ml. In patients with vitamin D insufficiency or deficiency, a large replacing dose (e.g. 50,000 IU capsules of D per week for 8-12 week) is recommended. Panel also suggested: the checking of the serum vitamin D, and calcium level, as well as, patients' compliance after the initial phase; a maintenance treatment of 1500-2000 IU daily or equivalent intermittent (weekly, biweekly or monthly) Dose, considering the patient's compliance; routine check of serum vitamin D level at least two times a year especially at the beginning of spring and autumn; Serum vitamin D evaluation for first degree relatives of MS patients at high risk age and supplementation in case of insufficiency (25(OH)D less than 40 ng/ml); correction of vitamin D deficiency and insufficiency before pregnancy, as well as, a daily dose of 1500-2000 IU or equivalent biweekly intake in 2nd and 3rd trimesters; stopping supplementation if 25(OH)D serum level exceeds 100 ng/ml. Although the results of high power studies are not available, correcting vitamin D status seems plausible in all MS and CIS patients. Maintaining the serum 25(OH)D level between 40 and 100 ng/ml is not known to exert adverse effect. More ever, it might be associated with lower disease activity.
Keywords: Assessment; Etiology; Multiple sclerosis; Pathogenesis; Treatment; Vitamin D.
Similar articles
-
Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.Mult Scler. 2009 Jun;15(6):735-40. doi: 10.1177/1352458509102844. Epub 2009 Apr 21. Mult Scler. 2009. PMID: 19383644
-
Association of vitamin D serum levels and vitamin D supplementation with B cell kinetics and disease activity in Multiple Sclerosis patients treated with ocrelizumab: an Italian multi-center study.Mult Scler Relat Disord. 2022 Dec;68:104395. doi: 10.1016/j.msard.2022.104395. Epub 2022 Nov 3. Mult Scler Relat Disord. 2022. PMID: 36544324
-
Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease.Anticancer Res. 2012 May;32(5):1991-8. Anticancer Res. 2012. PMID: 22593477
-
Vitamin D and multiple sclerosis: review of a possible association.J Pharm Pract. 2012 Feb;25(1):75-84. doi: 10.1177/0897190011421839. J Pharm Pract. 2012. PMID: 21987526 Review.
-
Vitamin D and multiple sclerosis: An update.Mult Scler Relat Disord. 2017 May;14:35-45. doi: 10.1016/j.msard.2017.03.014. Epub 2017 Mar 29. Mult Scler Relat Disord. 2017. PMID: 28619429 Review.
Cited by
-
Can Vitamin D Reduce Inflammation? The Influence of Supplementation on Selected Immunological Markers.Int J Mol Sci. 2024 Jul 11;25(14):7592. doi: 10.3390/ijms25147592. Int J Mol Sci. 2024. PMID: 39062835 Free PMC article.
References
-
- Jiao Z, Fu Y, Fu J, Zhang F, Wang W. 1, 25-dihydroxyvitamin D3 promotes the apoptosis of inflammatory cells in acute experimental autoimmune encephalomyelitis: experiment with rats. Zhonghua Yi Xue Za Zhi. 2008;88(33):2350–2354. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical